7th Oct 2014 08:27
Strong gains in the UK mining sector weren't enough to keep London's FTSE 100 from slipping into the red on Tuesday morning. Indices across Europe were tracking a weak finish on Wall Street and a mixed performance on Asian markets overnight. The FTSE 100 was trading 0.6% lower at 6,526 within the o
Read more25th Sep 2014 07:08
Sir Philip Hampton, the chairman of Royal Bank of Scotland (RBS) is to quit his role at in charge of the bank and take on the same role at pharmaceutical company GlaxoSmithKline (GSK), The Guardian reported on Thursday. Confirming rumours reported here on Wednesday, Hampton will succeed Sir Christop
Read more22nd Sep 2014 11:28
Avation: WH Ireland shifts target price from 200p to 206p and maintains a buy recommendation BAE Systems: UBS raises target price from 460p to 505p and reiterates a buy recommendation. Centrica: Goldman Sachs ups target price from 385p to 396p leaving its buy recommendation unchanged. Chariot Oil
Read more21st Sep 2014 18:48
Lloyds Banking Group is considering moving its legal home to England from Scotland even after the Scots voted against leaving the UK, the Mail on Sunday reported. Lloyds had said it would move if Scotland voted to leave the union but has only said it would keep "a significant presence" in Scotland a
Read more21st Sep 2014 15:56
Buy shares of GlaxoSmithKline, Questor said in the Sunday Telegraph. China's £297m fine against GSK for corruption is manageable and has lifted the cloud that hung over the company. The shares have underperformed the wider market and are trading on 15.3 times forecast earnings compared with 22 times
Read more19th Sep 2014 09:15
GlaxoSmithKline (GSK) has been found guilty in China of bribing non-government personnel with money or property to promote its products, the company revealed on Friday. The verdict follows investigations initiated by China's Ministry of Public Security in June 2013. The drugmaker's unit GSK China
Read more17th Sep 2014 10:10
Sixty healthy Britons will take part in a trial for a vaccine against Ebola at Oxford. The volunteers will be injected with the virus by experts at the University of Oxford in a fast-tracked process which aims to stop the spread of the fatal disease. The vaccine was developed by the US National Ins
Read more8th Sep 2014 15:41
Credit Suisse has slashed its earnings forecasts for Glaxosmithkline (GSK) before an expected restatement of divisional reporting at the pharmaceutical group. The bank has trimmed its target price for the stock from 1,475p to 1,400p and maintained an 'underperform' rating. It said that GSK's shares
Read more8th Sep 2014 11:36
Concerns surrounding the upcoming referendum on Scottish independence and a fragile ceasefire agreement in Ukraine were weighing heavily on UK stocks on Monday. London's FTSE 100 was trading down 1% at 6,789 by midday. The index has not closed below the 6,800 mark since 22 August when it settled at
Read more1st Sep 2014 15:24
UK pharmaceutical group GlaxoSmithKline (GSK) is facing rebellion from its shareholders as they call for an early departure from chairman Christopher Gent, reports said. Gent has been GSK's chairman for nine years, and announced earlier this year he would resign in 2015. However, shareholders wor
Read more1st Sep 2014 15:03
Shares in ITV were rising strongly on Monday on renewed speculation that Liberty Global could be preparing to launch a full-scale bid for the UK broadcaster. According to The Telegraph over the weekend, Liberty, which already owns a 6.4% stake in ITV through its investment in July, is "forming allia
Read more31st Aug 2014 17:42
Harris Associates, the US investment fund that has been one of Tesco's biggest and most loyal shareholders, has sold almost two thirds of its stake because it thinks the supermarket group has become too risky, the Sunday Telegraph reported. David Herro, Harris's chief executive, said there were too
Read more28th Aug 2014 10:08
Glaxosmithkline has been given permission to begin testing its Ebola virus vaccine on humans next week. The drugs giant and its partner on the experimental treatment, the US National Institutes of Health's Vaccine Research Centre, have been granted approval by the US Food and Drug Administration to
Read more26th Aug 2014 08:49
ViiV Healthcare, the specialist HIV company set up by GlaxoSmithKline and Pfizer, has received approval from the Food and Drug Administration (FDA) for Triumeq, its tablet form treatment of the HIV-1 infection. The treatment offers people a single-pill regimen containing dolutegravir, which was its
Read more26th Aug 2014 08:31
There is a lot to be said for value-based investment strategies as the year-to-date performance of The Daily Telegraph Questor column's six picks for 2014 show. They have held up despite market turbulence. The old stock market saying "never sell Shell" held true once again, with the shares deliverin
Read more